JP2025508359A5 - - Google Patents
Info
- Publication number
- JP2025508359A5 JP2025508359A5 JP2024546431A JP2024546431A JP2025508359A5 JP 2025508359 A5 JP2025508359 A5 JP 2025508359A5 JP 2024546431 A JP2024546431 A JP 2024546431A JP 2024546431 A JP2024546431 A JP 2024546431A JP 2025508359 A5 JP2025508359 A5 JP 2025508359A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- subject
- count
- composition according
- administration period
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263310751P | 2022-02-16 | 2022-02-16 | |
| US63/310,751 | 2022-02-16 | ||
| PCT/US2023/062731 WO2023159120A1 (en) | 2022-02-16 | 2023-02-16 | Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating hidradenitis suppurativa |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508359A JP2025508359A (ja) | 2025-03-26 |
| JP2025508359A5 true JP2025508359A5 (https=) | 2026-02-19 |
Family
ID=87579133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024546431A Pending JP2025508359A (ja) | 2022-02-16 | 2023-02-16 | 化膿性汗腺炎を治療するためのある特定のｎ－（１－シアノ－２－フェニルエチル）－１，４－オキサゼパン－２－カルボキサミド |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250144116A1 (https=) |
| EP (1) | EP4479059A4 (https=) |
| JP (1) | JP2025508359A (https=) |
| KR (1) | KR20240148350A (https=) |
| CN (1) | CN118695864A (https=) |
| AU (1) | AU2023221393A1 (https=) |
| CA (1) | CA3244131A1 (https=) |
| GB (1) | GB2630719A (https=) |
| IL (1) | IL314769A (https=) |
| MX (1) | MX2024009995A (https=) |
| WO (1) | WO2023159120A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2699580T3 (https=) | 2014-01-24 | 2018-02-24 | ||
| HUE070049T2 (hu) | 2018-03-01 | 2025-05-28 | Astrazeneca Ab | (2S)-{(1S)-1-ciano-2-[4-(3-metil-2-oxo-2,3-dihidro-1,3-benzoxazol-5-il)fenil]etil} -1,4-oxazepán-2-karboxamidot tartalmazó gyógyászati készítmények |
| WO2020018547A1 (en) | 2018-07-17 | 2020-01-23 | Insmed Incorporated | Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating lupus nephritis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2699580T3 (https=) * | 2014-01-24 | 2018-02-24 | ||
| KR20240091302A (ko) * | 2016-07-29 | 2024-06-21 | 인스메드 인코포레이티드 | 기관지확장증을 치료하기 위한 특정 (2s)-n-[(1s)-1-시아노-2-페닐에틸]-1,4-옥사제판-2-카르복스아미드 |
| CA3089240A1 (en) * | 2018-02-07 | 2019-08-15 | Insmed Incorporated | Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating anca associated vasculitides |
| MX2021012548A (es) * | 2019-04-17 | 2023-01-05 | Azora Therapeutics Inc | Composiciones topicas y metodos para el tratamiento de enfermedades inflamatorias de la piel. |
| WO2024026433A2 (en) * | 2022-07-28 | 2024-02-01 | Insmed Incorporated | Novel dpp1 inhibitors and uses thereof |
-
2023
- 2023-02-16 EP EP23757082.5A patent/EP4479059A4/en active Pending
- 2023-02-16 CN CN202380021843.7A patent/CN118695864A/zh active Pending
- 2023-02-16 GB GB2412566.8A patent/GB2630719A/en active Pending
- 2023-02-16 WO PCT/US2023/062731 patent/WO2023159120A1/en not_active Ceased
- 2023-02-16 IL IL314769A patent/IL314769A/en unknown
- 2023-02-16 US US18/838,823 patent/US20250144116A1/en active Pending
- 2023-02-16 MX MX2024009995A patent/MX2024009995A/es unknown
- 2023-02-16 KR KR1020247027154A patent/KR20240148350A/ko active Pending
- 2023-02-16 JP JP2024546431A patent/JP2025508359A/ja active Pending
- 2023-02-16 CA CA3244131A patent/CA3244131A1/en active Pending
- 2023-02-16 AU AU2023221393A patent/AU2023221393A1/en active Pending